Default company panoramic image
Bb50ba07 6ae3 4e72 ab43 5a88329605fc

Bioxiness Pharmaceuticals

Bioxiness is developing a novel class of antimicrobial compounds with a new mode of action for the treatment of severe bacterial infections.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Hercules, CA, USA
  • Currency USD
  • Founded October 2007
  • Employees 3
  • Website bioxiness.com

Company Summary

Bioxiness is developing a new class of antimicrobial compounds that can potentially be used against the fight in combating drug resistant pathogens - with an emphasis on gram-negative bacteria. The company is using a novel technology platform and has very encouraging data. Its IP has advanced to the international filing stage.

Team

  • Default avatar
    Richard Gless
    Head of Chemistry

  • Default avatar
    Mansour Bassiri
    CEO

  • Default avatar
    Reza Ilkhani
    CFO

  • Default avatar
    Paul Luciw
    Chair, Scientific Advisory Baord

  • Default avatar
    Clint Severson
    Board Member

Advisors

  • Default avatar
    Morrison & Foerster
    Lawyer
    Unconfirmed
    Default avatar
    RoseRyan
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Individual accredited investors
    Unconfirmed
    Default avatar
    (incl. a large pharma retired scientist with antibiotic background)
    Unconfirmed